top of page
What We Do
The GMDx Breakthrough
Immunotherapy Response Prediction
The GMDx Innate Immune Fitness (IIF) Score is the most accurate test developed today for predicting how patients will respond to cancer immunotherapy treatments.
Overall Accuracy
NVP
Innate Fitness Profile
The GMDx IFP Outperforms TMB and PD-L1 Tests
IFP
TMB
PD-L1
IFP: Innate Fitness Profile, TMB: Tumor Mutation Burden, PD-L1: Cell-based Biomarker, NPV: Negative predictive value ('who NOT to treat' is what oncologists want to know)
bottom of page